1[1]Zuutmond WW.Pain treatment with NSAIDs,primary focus on ibuprofen[J].Clin Rheumato,2001,20(Suppl 1):6-8.
2[2]Bon A,Jongejan RC.Treatment of non-malignant pain in the Dutch GP population:an analysis of treatment standards,prescription habits and basic attitudes[J].Clin Rheumatol,2001,20(Suppl 1):2-5.
3[3]Wollhim F.A New function for COX-2 in health and disease[J].Arthritis Research,1999,1(1):45-49.
4[4]Lipsky P.Cyclooxygenas research:advances with clinical implication[A].Emcry P.Rhcumatology highlights 1997[C].Oxford:Health Press,1997.24-29.
5[5]Evans AM.Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen[J].Clin Rheumatol,2001,20(Suppl 1):9-14.
6[6]Boneberg EM,Zou MH,Ullrich V.Inhibition of cyclooxygenase-1 and -2 by R(-)- and S(+)-ibuprofen[J].J Clin Pharmacol,1996,36(Suppl 12):16-19.
7[7]Walser S,Hruby R,Hesse E,et al.Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen(dexibuprofen) and R,S-ibuprofen in rats[J].Arzneimittelforschung,1997,47(6):750-754.
8[8]Gabard B,Nirnberger G,Schiel H,et al.Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen[J].Eur J Clin Pharmacol,1995,48(6):505-511.
9[9]Eller N,Kollenz CJ,Schiel H,et al.Pharmacokinetics of dexibuprofen administered as 200mg and 400mg film-coated tablets in healthy volunteers[J].Int J Clin Pharmacol Ther,1998,36(8):414-417.
10[10]Dionne RA,McCullagh L.Enhanced analgesia and suppression of plasma betaendorphin by the S(+)-isomer of ibuprofen[J].Clin Pharmacol Ther,1998,63(6):694-701.
8Tegon G,Pulzato L,Passarella L,et al.Randomized placebo-controlled trial on local applications of opioids after hemorrhoidectomy[J].Techniques in coloproctology,2009,13(3):219-224.
9Grass JA.Patient-controlled analgesia[J].Anesthesia and analgesia,2005,101(5 Suppl):S44-61.
10Moiniche S,Kehlet H,Dahl JB.A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief:the role of timing of analgesia[J].Anesthesiology,2002,96(3):725-741.
